A recent comprehensive review has identified extracellular vesicles (EVs) as a critical, conserved inter-organ communication language that bridges systemic comorbidities with the development of atherosclerosis. Traditionally, clinical risk frameworks have struggled to account for a substantial residual cardiovascular burden observed in patients suffering from diverse systemic conditions, including obesity, diabetes, metabolic-associated steatotic liver disease (MASLD), and chronic infections. This research proposes that these disparate conditions utilize EVs to translate pathological signals into convergent vascular dysfunction, potentially reframing atherosclerosis as a systemic disorder of disrupted crosstalk between organs.
The study introduces an integrative “encode-transport-decode” working model to explain how this process occurs. Within this framework, diseased tissues selectively package pathogenic microRNAs and proteins into EVs. These vesicles circulate stably throughout the body until they reach vascular recipient cells, where they unpack their contents and activate a restricted, pro-atherogenic signaling repertoire. Despite the varied clinical origins of the vesicles, the researchers identified that they converge on the same biological pathways in the cardiovascular system.
Specifically, the investigation highlights three synergistic axes where these EV-mediated signals operate. First, the cargo induces NF-κB-driven disruption of the endothelial barrier. Second, the signals suppress the PPARγ-LXRα-ABCA1/ABCG1 pathways, which significantly impairs cholesterol efflux. Finally, these vesicles drive systemic inflammatory immune reprogramming. By acting through these unified mechanisms, EVs allow diverse systemic states to coordinate their impact on vascular health, even when the original diseases appear biologically unrelated.
Building on these observations, the authors introduce a convergent synergy hypothesis. This proposal suggests that when multiple comorbidities coexist, they do not simply add to one another but produce cumulative and synergistic vascular damage that exceeds the sum of their individual effects.
Translational applications for this discovery are promising. The researchers suggest that specific EV signatures could be utilized for dynamic risk stratification in patients with multiple morbidities.
Despite the potential for precision interventions, the review notes significant remaining hurdles. Additionally, researchers must still decipher the complex rules that govern how diseased tissues determine which cargo to sort into EVs under stress.
Subject of Research: Extracellular vesicle-mediated inter-organ communication in atherosclerosis
Article Title: Extracellular vesicles as inter-organ messengers in atherogenesis: convergent pathways linking systemic comorbidities to vascular dysfunction
Article References: Liu, Y., Chen, C., Yuan, Y., Cheng, W., & Zhang, H.-G. (2026). Extracellular vesicles as inter-organ messengers in atherogenesis: convergent pathways linking systemic comorbidities to vascular dysfunction. Molecular Medicine. https://doi.org/10.1186/s10020-026-01680-5
Image Credits: AI Generated
DOI: 10.1186/s10020-026-01680-5
Keywords: Extracellular vesicles, Atherogenesis, Vascular dysfunction, Systemic comorbidities, Inter-organ communication, MicroRNA, Pathogenic proteins, Endothelial barrier, PPARγ-LXRα-ABCA1/ABCG1, Inflammatory signaling, MASLD, Diabetes, Obesity, Cardiovascular disease, Translational medicine, Lipid metabolism, Immune reprogramming
News Source: Ophelia Keating. (November 18, 2026). Extracellular Vesicles Link Systemic Comorbidities to Vascular Dysfunction in Atherogenesis. Scienmag.



